Artificial Intelligence (AI) has revolutionized the modeling of human adaptive energy expenditure, offering unprecedented accuracy and dynamic insights into metabolic processes. This review elucidates the integration of AI in quantifying and predicting energy expenditure, with a focus on clinical utility, mechanistic understanding, and future directions. By synthesizing recent PubMed-indexed research, we highlight AI's transformative potential in metabolic medicine, obesity, and chronic disease management.
Adaptive energy expenditure (AEE) is a fundamental physiological process reflecting the body's ability to adjust energy output in response to internal and external stimuli. Traditional models have relied on static or population-based estimations, often lacking sensitivity to real-time individual variation. The advent of AI, particularly machine learning (ML) and deep learning (DL), has enabled the development of more precise, personalized, and adaptive models. These models leverage multimodal data, including wearable sensor outputs, genomics, and behavioral metrics, to provide a comprehensive view of energy metabolism. For clinicians, understanding and utilizing AI-driven AEE modeling is increasingly critical for personalized nutrition, weight management, and metabolic disease interventions.
Metabolic disorders, including obesity, diabetes mellitus, and metabolic syndrome, have reached epidemic proportions globally, affecting hundreds of millions of individuals. The burden of these conditions is intimately linked to dysregulated energy balance and expenditure. Inaccurate assessment of energy expenditure can lead to suboptimal management strategies in both preventive and therapeutic settings. Recent epidemiological data underscore the heterogeneity of AEE across populations, influenced by age, sex, ethnicity, comorbidities, and lifestyle factors. As such, precision medicine approaches empowered by AI are urgently needed to address the vast and growing burden of metabolic diseases.
AEE is governed by a complex interplay between basal metabolic rate (BMR), thermic effect of food, physical activity, and adaptive thermogenesis. Physiological adaptation to energy imbalance, environmental changes, and pharmacologic interventions is mediated through neuroendocrine, mitochondrial, and molecular pathways. AI-based modeling facilitates the deconvolution of these multifactorial influences by analyzing high-dimensional data sets. Deep neural networks, for example, can uncover non-linear relationships between genetic polymorphisms, hormonal signals (such as leptin and ghrelin), and environmental exposures that influence adaptive thermogenesis. This mechanistic insight is invaluable for designing targeted interventions for metabolic optimization.
Numerous risk factors modulate AEE, including genetic predisposition, age-related sarcopenia, sedentary behavior, nutritional status, pharmacotherapy, and chronic disease states. AI-enabled predictive analytics can stratify individuals based on risk profiles, identifying those with impaired or exaggerated adaptive responses. For instance, recent studies utilizing ML algorithms have identified phenotypes of "adaptive resistance" in weight-reduced individuals, which may predispose to weight regain. Early identification of such risk factors can inform preventive strategies and guide personalized therapeutic plans.
Clinically, altered AEE manifests as unexplained weight fluctuations, plateauing during weight loss interventions, and variable responses to caloric restriction or exercise regimens. AI-powered modeling of continuous physiologic data such as heart rate variability, actigraphy, and indirect calorimetry has improved the clinical detection and interpretation of these features. Such advancements enable the real-time monitoring of metabolic adaptation, allowing clinicians to dynamically adjust interventions in response to emerging trends in energy expenditure.
Traditional diagnostic approaches to assessing energy expenditure, such as doubly labeled water and indirect calorimetry, are resource-intensive and often impractical for routine or longitudinal use. AI-based models, trained on large-scale datasets, can accurately predict energy expenditure from less invasive and more accessible data sources, including wearable sensors and electronic health records (EHRs). These models have demonstrated robust performance in both research and clinical settings, offering improved diagnostic sensitivity and specificity for metabolic adaptations. Integration of AI-driven diagnostics into clinical practice promises to democratize access to advanced metabolic assessments.
The management of metabolic disorders hinges on accurate estimation and modulation of energy expenditure. AI models facilitate personalized treatment, enabling tailored dietary, pharmacologic, and behavioral interventions. Examples include adaptive calorie prescriptions in obesity management, dynamic adjustment of exercise regimens, and real-time feedback for glucose control in diabetes. Machine learning platforms can also predict patient responses to interventions, reducing trial-and-error approaches and enhancing therapeutic efficacy. Importantly, AI-driven insights support shared decision-making between clinicians and patients, improving engagement and adherence to management plans.
Recent years have seen rapid advances in AI methodologies applied to AEE modeling. Convolutional neural networks (CNNs) and recurrent neural networks (RNNs) are being utilized to interpret complex temporal and spatial data from wearables, enhancing the granularity and predictive power of energy expenditure estimates. Integration of multi-omics data genomics, proteomics, metabolomics through AI frameworks is paving the way for systems-level understanding of energy metabolism. Emerging therapies, such as AI-guided digital coaching and closed-loop metabolic intervention platforms, are under active investigation and hold promise for real-time, adaptive management of metabolic health.
Current clinical guidelines acknowledge the importance of individualized assessment of energy expenditure but are only beginning to incorporate AI-based tools. Leading organizations recommend the use of validated digital health technologies, including AI-driven wearables and mobile applications, for monitoring and supporting lifestyle interventions in at-risk populations. Ongoing guideline revisions are likely to further emphasize the integration of AI into routine care, particularly as evidence accumulates regarding its safety, accuracy, and clinical utility. Clinicians are encouraged to stay abreast of evolving best practices and regulatory considerations in the deployment of AI in metabolic medicine.
AI-driven modeling of human adaptive energy expenditure represents a paradigm shift in metabolic medicine, offering unprecedented precision, scalability, and clinical relevance. By harnessing vast and diverse data sources, AI models can elucidate complex physiological processes, inform risk stratification, and enable truly personalized interventions. As these technologies continue to mature and integrate into clinical workflows, they have the potential to dramatically improve outcomes for patients with metabolic disorders. Continued research, validation, and guideline development will be essential to fully realize the benefits of AI in this rapidly evolving field.
1.
More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
2.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
3.
We Don't Always Know What's 'Best' for Our Patients
4.
Should the UK introduce targeted prostate cancer screening? The case for and against
5.
Germline Profiling May Improve Risk Stratification in t-MNs
1.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
2.
Vaccines that can help prevent cancer
3.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
4.
Liquid Biopsy in Hematologic Malignancies: Current Evidence and Clinical Applications
5.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
Case-Based Learning: Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation